![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 22, 19754-19761, May 31, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Division of Endocrinology, Diabetes, and Metabolism,
Departments of Medicine and Genetics and The Penn Diabetes Center,
University of Pennsylvania School of Medicine, Philadelphia,
Pennsylvania 19104
Resistin, also known as Adipocyte
Secreted Factor (ADSF) and Found in
Inflammatory Zone 3 (FIZZ3), is a mouse
protein with potential roles in insulin resistance and adipocyte
differentiation. The resistin gene is expressed almost exclusively in
adipocytes. Here we show that a proximal 264-base pair fragment of the
mouse resistin promoter is sufficient for expression in adipocytes. Ectopic expression of the adipogenic transcription factor
CCAAT/enhancer-binding protein (C/EBP
Mechanisms Regulating Adipocyte Expression of
Resistin*
,
,
) was sufficient for
expression in non-adipogenic cells. C/EBP
binds specifically to a
site that is essential for expression of the resistin promoter.
Chromatin immunoprecipitation studies of the endogenous gene
demonstrated adipocyte-specific association of C/EBP
with the
proximal resistin promoter in adipocytes but not preadipocytes.
C/EBP
binding was associated with the recruitment of coactivators
p300 and CREB-binding protein and a dramatic increase in histone
acetylation in the vicinity of the resistin promoter. The antidiabetic
thiazolidinedione (TZD) drug rosiglitazone reduced resistin expression
with an ED50 similar to its Kd
for binding to peroxisome proliferator activated receptor
(PPAR
). Other TZD- and non-TZD PPAR
ligands also down-regulated
resistin expression. However, no functional PPAR
binding site was
found within 6.2 kb of the transcriptional start site, suggesting that
if PPAR
is involved, it is either acting at a long distance from the
start site, in an intron, or indirectly. Nevertheless,
rosiglitazone treatment selectively decreased histone acetylation
at the resistin promoter without a change in occupation by C/EBP
,
CREB-binding protein, or p300. Thus, adipocyte specificity of resistin
gene expression is because of C/EBP
binding, leading to the
recruitment of transcriptional coactivators and histone acetylation
that is characteristic of an active chromatin environment. TZD reduces
resistin gene expression at least in part by reducing histone
acetylation associated with the binding of C/EBP
in mature adipocytes.
*
This work was supported by NIDDK, National Institutes
of Health Grants DK49780 and DK49210 (to M. A. L.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Both authors contributed equally to this work.
§
To whom correspondence should be addressed: University of
Pennsylvania, School of Medicine, 611 CRB, 415 Curie Blvd.,
Philadelphia, PA 19104-6149. Tel.: 215-898-0198; Fax: 215-898-5408;
E-mail: lazar@mail.med.upenn.edu.
This article has been cited by other articles:
![]() |
S. R. Farmer Molecular determinants of brown adipocyte formation and function Genes & Dev., May 15, 2008; 22(10): 1269 - 1275. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Arenillas, M. A. Moro, and A. Davalos The Metabolic Syndrome and Stroke: Potential Treatment Approaches Stroke, July 1, 2007; 38(7): 2196 - 2203. [Full Text] [PDF] |
||||
![]() |
T. T. C. Yang, H. Y. Suk, X. Yang, O. Olabisi, R. Y. L. Yu, J. Durand, L. A. Jelicks, J.-Y. Kim, P. E. Scherer, Y. Wang, et al. Role of Transcription Factor NFAT in Glucose and Insulin Homeostasis Mol. Cell. Biol., October 15, 2006; 26(20): 7372 - 7387. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Chen, M.-J. Lee, H.-H. Chang, P.-F. Hung, and Y.-H. Kao 17{beta}-Estradiol Stimulates Resistin Gene Expression in 3T3-L1 Adipocytes via the Estrogen Receptor, Extracellularly Regulated Kinase, and CCAAT/Enhancer Binding Protein-{alpha} Pathways Endocrinology, September 1, 2006; 147(9): 4496 - 4504. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Salma, H Xiao, and A N Imbalzano Temporal recruitment of CCAAT/enhancer-binding proteins to early and late adipogenic promoters in vivo J. Mol. Endocrinol., February 1, 2006; 36(1): 139 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. Liu, Y.-H. Chen, P.-F. Hung, and Y.-H. Kao Inhibitory effect of green tea (-)-epigallocatechin gallate on resistin gene expression in 3T3-L1 adipocytes depends on the ERK pathway Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E273 - E281. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Qiao, P. S. MacLean, J. Schaack, D. J. Orlicky, C. Darimont, M. Pagliassotti, J. E. Friedman, and J. Shao C/EBP{alpha} Regulates Human Adiponectin Gene Transcription Through an Intronic Enhancer Diabetes, June 1, 2005; 54(6): 1744 - 1754. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bokarewa, I. Nagaev, L. Dahlberg, U. Smith, and A. Tarkowski Resistin, an Adipokine with Potent Proinflammatory Properties J. Immunol., May 1, 2005; 174(9): 5789 - 5795. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Chen, P.-F. Hung, and Y.-H. Kao IGF-I downregulates resistin gene expression and protein secretion Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E1019 - E1027. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Lee, J. W. Bullen Jr., V. L. Stoyneva, and C. S. Mantzoros Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia Am J Physiol Endocrinol Metab, March 1, 2005; 288(3): E625 - E632. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-P. Guan, T. Ishizuka, P. C. Chui, M. Lehrke, and M. A. Lazar Corepressors selectively control the transcriptional activity of PPAR{gamma} in adipocytes Genes & Dev., February 15, 2005; 19(4): 453 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Temple, R. N. Cohen, S. R. Wondisford, C. Yu, D. Deplewski, and F. E. Wondisford An Intact DNA-binding Domain Is Not Required for Peroxisome Proliferator-activated Receptor {gamma} (PPAR{gamma}) Binding and Activation on Some PPAR Response Elements J. Biol. Chem., February 4, 2005; 280(5): 3529 - 3540. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Haugen, N. Zahid, K. T. Dalen, K. Hollung, H. I. Nebb, and C. A. Drevon Resistin expression in 3T3-L1 adipocytes is reduced by arachidonic acid J. Lipid Res., January 1, 2005; 46(1): 143 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Rochford, R. K. Semple, M. Laudes, K. B. Boyle, C. Christodoulides, C. Mulligan, C. J. Lelliott, S. Schinner, D. Hadaschik, M. Mahadevan, et al. ETO/MTG8 Is an Inhibitor of C/EBP{beta} Activity and a Regulator of Early Adipogenesis Mol. Cell. Biol., November 15, 2004; 24(22): 9863 - 9872. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-k. Park, S.-Y. Oh, M.-Y. Lee, S. Yoon, K.-S. Kim, and J.-w. Kim CCAAT/Enhancer Binding Protein and Nuclear Factor-Y Regulate Adiponectin Gene Expression in Adipose Tissue Diabetes, November 1, 2004; 53(11): 2757 - 2766. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Liu, H. Jin, M. Ullenbruch, B. Hu, N. Hashimoto, B. Moore, A. McKenzie, N. W. Lukacs, and S. H. Phan Regulation of Found in Inflammatory Zone 1 Expression in Bleomycin-Induced Lung Fibrosis: Role of IL-4/IL-13 and Mediation via STAT-6 J. Immunol., September 1, 2004; 173(5): 3425 - 3431. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Felipe, M. L. Bonet, J. Ribot, and A. Palou Modulation of Resistin Expression by Retinoic Acid and Vitamin A Status Diabetes, April 1, 2004; 53(4): 882 - 889. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Miner The adipocyte as an endocrine cell J Anim Sci, March 1, 2004; 82(3): 935 - 941. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Banerjee, S. M. Rangwala, J. S. Shapiro, A. S. Rich, B. Rhoades, Y. Qi, J. Wang, M. W. Rajala, A. Pocai, P. E. Scherer, et al. Regulation of Fasted Blood Glucose by Resistin Science, February 20, 2004; 303(5661): 1195 - 1198. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bays, L. Mandarino, and R. A. DeFronzo Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 463 - 478. [Full Text] [PDF] |
||||
![]() |
J. H. Lee, J. L. Chan, N. Yiannakouris, M. Kontogianni, E. Estrada, R. Seip, C. Orlova, and C. S. Mantzoros Circulating Resistin Levels Are Not Associated with Obesity or Insulin Resistance in Humans and Are Not Regulated by Fasting or Leptin Administration: Cross-Sectional and Interventional Studies in Normal, Insulin-Resistant, and Diabetic Subjects J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4848 - 4856. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Kennell, E. E. O'Leary, B. M. Gummow, G. D. Hammer, and O. A. MacDougald T-Cell Factor 4N (TCF-4N), a Novel Isoform of Mouse TCF-4, Synergizes with {beta}-Catenin To Coactivate C/EBP{alpha} and Steroidogenic Factor 1 Transcription Factors Mol. Cell. Biol., August 1, 2003; 23(15): 5366 - 5375. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Seo, M. J. Noh, E. J. Yoo, S. Y. Park, J. Park, I. K. Lee, S. D. Park, and J. B. Kim Functional Characterization of the Human Resistin Promoter with Adipocyte Determination- and Differentiation-Dependent Factor 1/Sterol Regulatory Element Binding Protein 1c and CCAAT Enhancer Binding Protein-{alpha} Mol. Endocrinol., August 1, 2003; 17(8): 1522 - 1533. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Stutz, L. A. Pickart, A. Trifilieff, T. Baumruker, E. Prieschl-Strassmayr, and M. Woisetschlager The Th2 Cell Cytokines IL-4 and IL-13 Regulate Found in Inflammatory Zone 1/Resistin-Like Molecule {alpha} Gene Expression by a STAT6 and CCAAT/Enhancer-Binding Protein-Dependent Mechanism J. Immunol., February 15, 2003; 170(4): 1789 - 1796. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |